|
| |
Articles
1-46 out of 46 article(s)
| Title |
Author |
Type |
Date |
Words |
| Policy & practice. |
Anderson, Jane |
Report |
Mar 15, 2013 |
644 |
| Akathisia--rare cause of psychomotor agitation in patients with traumatic brain injury: case report and review of literature. |
Wielenga-Boiten, Janet E.; Ribbers, Gerard M. |
Case study |
Sep 1, 2012 |
3150 |
| Psychoactive properties of alpha-methyltryptamine: analysis from self reports of users. |
Wilcox, James |
Report |
Sep 1, 2012 |
1948 |
| Antipsychotics need to pile up: new insights explain delayed action in schizophrenia drugs. |
Sanders, Laura |
|
Jul 14, 2012 |
445 |
| Off-label use of atypicals proves minimally effective. |
Moon, Mary Ann |
|
Nov 1, 2011 |
483 |
| Groups back forcing meds. |
Correa, Frances |
Brief article |
Sep 1, 2011 |
158 |
| Link tightens between antipsychotics and VTE: association strongest in patients who started an antipsychotic in past 3 months. |
Wachter, Kerri |
|
Oct 15, 2010 |
1537 |
| Antipsychotic use tied to venous thromboembolism risk. |
Wachter, Kerri |
Clinical report |
Oct 1, 2010 |
887 |
| 'Think outside the box' in treating anorexia. |
Wendling, Patrice |
|
Jun 1, 2010 |
979 |
| Anticonvulsant warning led to decreased use. |
Guilford-Blake, Roxanna |
|
May 1, 2010 |
604 |
| Antipsychotic polypharmacy in schizophrenic inpatients/Yatan sizofreni hastalarinda coklu antipsikotik kullanimi. |
Ozalmete, Ozlem Albayrak; Ceylan, Mehmet Emin; Ozalmete, Onur; Sevim, Meltem Efe |
Report |
Mar 1, 2010 |
4176 |
| Suicide risk in schizophrenia--a follow-up study after 20 years: Part 2: symptomatology and pharmacotherapy. |
Lippi, G.; Smit, D.J.; Jordaan, J.C.; Ross, J.L. |
Clinical report |
Dec 1, 2009 |
4735 |
| Adolescent-onset psychosis: a 2-year retrospective study of adolescents admitted to a general psychiatric unit. |
Paruk, S.; Ramlall, S.; Burns, J.K. |
Clinical report |
Dec 1, 2009 |
4392 |
| Lilly paid doctors to prescribe Zyprexa, notes show. |
|
|
Sep 14, 2009 |
403 |
| Bipolar disorder ups risk for lipid disorders. |
McNamara, Damian |
Clinical report |
Sep 1, 2009 |
565 |
| AstraZeneca Plc. |
|
Brief article |
Mar 2, 2009 |
174 |
| Prevalence of metabolic syndrome, characteristics of metabolic syndrome and relationship with the antipsychotics used in schizophrenia/Sizofrenide metabolik sendrom sikligi, metabolik sendromun ozellikleri ve kullanilan antipsikotiklerle iliskisi. |
Kaya, Mehmet Cemal; Virit, Osman; Altindag, Abdurrahman; Selek, Salih; Bulbul, Feridun; Bulut, Mahmu |
Clinical report |
Mar 1, 2009 |
4488 |
| AstraZeneca Plc. |
|
Brief article |
Feb 2, 2009 |
173 |
| The use of lamotrigine for seizures and psychiatric disorder and its effects on challenging behavior. |
Hoheneck, Dagmar; Bachmeier, Barbara |
Report |
Oct 1, 2008 |
3061 |
| Among women with schizophrenia who are being treated with antipsychotic medications, an estrogen patch can markedly improve their symptoms, results of a clinical trial show. |
|
Brief article |
Aug 11, 2008 |
285 |
| Can medication response confirm a diagnosis? |
Levitas, Andrew S.; Hurley, Anne D. |
Report |
Jul 1, 2008 |
2347 |
| People with dementia more than tripled their risk of death or hospitalization within a month of taking antipsychotic drugs to silence their agitation, according to a study. |
|
Brief article |
Jun 2, 2008 |
309 |
| Lawsuits challenge use of 'chemical restraints' in nursing homes. |
Jablow, Valerie |
|
Mar 1, 2008 |
2003 |
| Nursing homes' use of antipsychotics edges down. |
Dixon, Bruce K. |
Survey |
Dec 15, 2007 |
1038 |
| Rivastigmine good choice for Parkinson's dementia. |
Sullivan, Michele G. |
|
Sep 1, 2006 |
453 |
| CATIE support of atypical antipsychotics debated. |
Kirn, Timothy F. |
Drug overview |
Jul 1, 2006 |
1209 |
| Atypical antipsychotics can improve behavior in dementia. |
Wachter, Kerri |
|
Jun 15, 2006 |
255 |
| Aripiprazole found effective in prolonged, comorbid delirium. |
MacNeil, Jane Salodof |
|
May 1, 2006 |
632 |
| Drug-induced parkinsonism often missed by experts: the older, conventional antipsychotic drugs have been most commonly associated with the problem. |
Wachter, Kerri |
Statistical data |
Apr 1, 2006 |
799 |
| Olanzapine, haloperidol, and weight. |
Kirn, Timothy F. |
Brief article |
Mar 1, 2006 |
219 |
| Some symptoms of PDD respond to medications: pharmacotherapy has shown some promise for reducing aggression, inattention, and hyperactivity. |
Sullivan, Michele G. |
|
Feb 1, 2006 |
638 |
| Risperidone use linked to pituitary tumors. |
Zoler, Mitchel L. |
|
Jan 1, 2006 |
853 |
| Tapering off medications even with recent-onset schizophrenia a bad idea. |
Melville, Nancy A. |
Statistical data |
Jan 1, 2006 |
495 |
| Some developmentally disabled see benefits from aripiprazole. |
Splete, Heidi |
Statistical data |
Nov 1, 2005 |
403 |
| Treatment response and compliance are rarely absolute in schizophrenia. |
Sherman, Carl |
|
Aug 1, 2005 |
543 |
| Metabolic issues in patients with severe mental illness. |
Damatarca, Cristina |
|
Jul 1, 2005 |
5817 |
| Antipsychotic use in young children. |
Splete, Heidi |
Brief Article |
May 1, 2005 |
119 |
| Atypicals in dual-diagnosis patients. |
Foley, Kevin |
Brief Article |
Mar 1, 2005 |
136 |
| Broad approach required in treating agitation, psychosis. |
Finn, Robert |
|
Feb 1, 2005 |
505 |
| Mortality on antipsychotics. |
Evans, Jeff |
Brief Article |
Aug 1, 2004 |
157 |
| Olanzapine for stuttering. |
Evans, Jeff |
Brief Article |
Aug 1, 2004 |
92 |
| Ziprasidone may improve cognition in schizophrenia. |
Norton, Patrice G.W. |
|
Aug 1, 2004 |
787 |
| Court to decide if defendant can be forcibly medicated. (State to State). |
St. Gerard, Vanessa |
Brief Article |
Jul 1, 2003 |
230 |
| Clozaril. (New & Approved). |
Mechacatie, Elizabeth |
Brief Article |
Feb 15, 2003 |
343 |
| Antipsychotic drug doses climb over time. |
Bower, Bruce |
|
Jun 13, 1992 |
557 |
| Vitamin E may ease movement disorder. |
Bower, Bruce |
Brief Article |
May 23, 1992 |
295 |
|
